U.S. flag

An official website of the United States government

NM_201589.4(MAFA):c.170C>G (p.Thr57Arg) AND Islet cell adenomatosis

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 4, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003325633.2

Allele description [Variation Report for NM_201589.4(MAFA):c.170C>G (p.Thr57Arg)]

NM_201589.4(MAFA):c.170C>G (p.Thr57Arg)

Gene:
MAFA:MAF bZIP transcription factor A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
8q24.3
Genomic location:
Preferred name:
NM_201589.4(MAFA):c.170C>G (p.Thr57Arg)
HGVS:
  • NC_000008.11:g.143430237G>C
  • NM_201589.4:c.170C>GMANE SELECT
  • NP_963883.2:p.Thr57Arg
  • NC_000008.10:g.144512407G>C
Protein change:
T57R
Molecular consequence:
  • NM_201589.4:c.170C>G - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Name:
Islet cell adenomatosis
Identifiers:
MONDO: MONDO:0007834; MedGen: C1578917; OMIM: 147630

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004031436Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 4, 2023)
germlineclinical testing

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes61not providednot providednot providedclinical testing
not providedgermlineunknown61not providednot providednot providedclinical testing

Citations

PubMed

Second MAFA Variant Causing a Phosphorylation Defect in the Transactivation Domain and Familial Insulinomatosis.

Fottner C, Sollfrank S, Ghiasi M, Adenaeuer A, Musholt T, Schad A, Miederer M, Schadmand-Fischer S, Weber MM, Lackner KJ, Rossmann H.

Cancers (Basel). 2022 Apr 1;14(7). doi: 10.3390/cancers14071798.

PubMed [citation]
PMID:
35406570
PMCID:
PMC8997416

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, SCV004031436.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (2)
2not provided4not providednot providedclinical testing PubMed (2)
3not provided6not providednot providedclinical testing PubMed (2)

Description

two sisters suffered from adult-onset insulinomatosis

4 further heterozygous relatives showed a MODY-like form of diabetes mellitus

Six other relatives carried the variant in heterozygous form, but no information was available on their blood glucose status. Four of these are childre, too young to develop symptoms (3-7 years of age).

Description

Using exome sequencing (conformation using Sanger Sequencing), we detected a novel, heterozygous missense variant, c.170C>G p.(Thr57Arg), in MAFA’s highly conserved transactivation domain in two sisters who suffer from adult-onset familial insulinomatosis. Furthermore, mild hyperglycemia was observed in six additional, heterozygote family members, indicating that not only insulinomatosis but also MODY-like symptoms co-segregate with p.Thr57Arg. Details on methods, family and clinical details can be found in PMID: 35406570. In vitro expression studies replacing Thr57 have already been performed by Han et al., demonstrating a phosphorylation defect with impairment of transactivation activity and degradation (PMID: 17682063). The MAFA variant, p.Ser64Phe, is located in the same domain, impairs the same phosphorylation cascade, and results in the same symptoms (PMID: 29339498). Therfore, we classified the variant NM_201589.4(MAFA):c.170C>G as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided2not provided1not provided
2germlineyesnot providednot providednot provided4not provided1not provided
3germlineunknownnot providednot providednot provided6not provided1not provided

Last Updated: Jun 23, 2024